Healthpeak Properties' Q2 2026 Earnings: What to Expect

Healthpeak Properties (NYSE:DOC) highlighted Q2 results and updates on capital recycling and leasing. It recapitalized a Brookfield outpatient portfolio, retaining 51% interest and raising $1B cash, and noted a 5.9% trailing cash cap rate. Lab occupancy rose to 78.5%. Net debt/adj. EBITDA was 4.7x with $4.1B liquidity; it repaid $900M debt and repurchased $100M shares.

Healthpeak Properties (DOC) is a U.S. healthcare REIT with a $14.9B market cap. The stock rose 31.8% over the past year and nearly 41% in 2026. After Q2 2026 results on Aug. 4, revenue was $771.6M and adjusted FFO was $0.46, both above estimates. Full-year FFO guidance is $1.73 to $1.77. Analysts rate DOC a “Moderate Buy,” with Barclays holding a $23 target.

HEALTHPEAK PROPERTIES, INC. (DOC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.3 4 ex99306302026.htm EX-99.3 Document Exhibit 99.3 Discussion and Reconciliation of Healthpeak's Non-GAAP Financial Measures June 30, 2026 (Unaudited) Definitions Adjusted Fixed Charge Coverage Fixed Charge Coverage Adjusted EBITDAre divided by Fixed Charges. Adjusted Fixe

Brookfield Asset Management and its affiliates formed a joint venture with Healthpeak Properties to obtain a 49% interest in Healthpeak’s 86 outpatient medical buildings nationwide, valued at about $2.1B. The portfolio totals about 5.6M sq ft across 11 states and is 95% leased, per the announcement. Healthpeak keeps 51% control and received about $1B in gross proceeds.

Brookfield Asset Management will form a U.S. outpatient medical buildings joint venture with Healthpeak Properties. Healthpeak will contribute 86 properties valued at about US$2.1 billion. Brookfield and affiliates will hold 49% and receive about US$1.03 billion in gross proceeds, while Healthpeak holds 51% and manages. The portfolio is 95% leased across 11 states.

Scotiabank raised its price target for Healthpeak Properties (NYSE:DOC) from $19.00 to $21.00 and kept a “sector perform” rating, implying about 4.19% upside from the prior close, according to the note reported by Benzinga. The article also cites other analyst target changes and notes DOC traded at $20.16 on Wednesday.